International Conference on Neurogenetics and Genomic Medicine
ICNGGM
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore the latest discoveries in neurogenetics, focusing on the genetic underpinnings of neurological disorders. Researchers will present novel findings that enhance our understanding of gene-environment interactions in neurodevelopment.
SDG 3
SDG 4
This session will address the integration of genomic medicine into clinical neurology, highlighting case studies and innovative approaches. Discussions will focus on how genomic data can inform diagnosis and treatment strategies for neurological conditions.
SDG 3
SDG 9
This track will delve into hereditary neurological disorders, emphasizing the genetic factors that contribute to their pathogenesis. Presentations will cover a range of conditions, from rare genetic syndromes to more common hereditary diseases.
SDG 3
SDG 4
This session will focus on the role of genomic diagnostics in the identification and management of neurological disorders. Experts will discuss the implementation of next-generation sequencing technologies and their impact on patient outcomes.
SDG 3
SDG 9
This track will examine the principles of precision neurology, where treatments are customized based on individual genetic profiles. Participants will explore the challenges and successes of personalized therapeutic approaches in neurological practice.
SDG 3
SDG 9
This session will highlight the intersection of neurogenomics and biomarker identification, focusing on the potential of genetic markers in predicting disease progression. Researchers will present their findings on biomarkers that could revolutionize clinical practice.
SDG 3
SDG 9
This track will explore the emerging field of gene therapy as a treatment modality for various neurological disorders. Presentations will cover recent clinical trials and the potential of gene editing technologies to address genetic causes of disease.
SDG 3
SDG 9
This session will discuss the importance of genetic testing and counseling in the management of neurological conditions. Experts will share best practices for integrating genetic information into patient care and decision-making.
SDG 3
SDG 4
This track will address the ethical implications of neurogenetic research and its applications in clinical settings. Discussions will focus on issues such as informed consent, privacy, and the potential for genetic discrimination.
SDG 16
This session will focus on the genetic factors influencing neurodevelopmental disorders, such as autism spectrum disorders and ADHD. Researchers will present findings that elucidate the genetic architecture and environmental interactions involved.
SDG 3
SDG 4
This track will provide insights into the future landscape of neurological genetics research, emphasizing innovative methodologies and interdisciplinary collaborations. Participants will discuss emerging trends and the potential for transformative breakthroughs in the field.
SDG 3
SDG 9